Author : Anjali sudha
Keyword : Asthma, a bronchodilator, β-adrenoceptor agonist, muscarinic antagonist; theophylline, cromoglycate, corticosteroids, nanoformulations introduction:
Subject : Pharmacy
Article Type : Review article
Article QR Code
Article File : Full Text PDF
Abstract : It is the compilation of information related to the latest situation which cures asthma. In this paper, there is a discussion concerning the recent developments in asthma treatment and their reorganization. Standard care for the majority of patients to deal with it is inhaled corticosteroids (ICS), and individuals who are not compliant with this treatment are recommended to take it with a combination of beta2 agonists as an inhaler. For severe conditions where asthma is difficult to control, biological therapies such as immunoglobulin E or interleukin-5 targeting might be helpful, as per recent studies. Allergen-specific immunotherapy, if prescribed by the physician along with accurate training regarding allergy for asthma patients, is found to be one of the most potential disease-modifying therapy.
Article by : anjali
Article add date : 2023-09-12
How to cite : Anjali sudha. (2023-September-12). A review article on recent development in the asthma treatment. retrieved from https://www.openacessjournal.com/abstract/1346